SEARCH RESULTS FOR: "Tag: BMY"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2022(1)
2021(3)
2020(3)
2019(11)
2018(6)
2017(9)
2016(13)
2015(10)
2014(3)
CATEGORIES
Analyst Downgrades(3)
Analyst Update(5)
Analyst Upgrades(1)
Best and Worst Stocks(1)
Buzz Stocks(8)
Earnings Preview(1)
Editor's Pick(1)
Expectational Analysis(1)
General(8)
Indicator of the Week(1)
Intraday Option Activity(6)
Midday Market Check(7)
Opening View(4)
Options Recommendations(1)
Quantitative Analysis(2)
Stock Market News(5)
Stocks On the Move(9)
The Week Ahead(2)
Trader Content(1)
Unusual Trading Activity(1)

4/6/2022 2:01 PM
The shares of Bristol-Myers Squibb Co (NYSE:BMY) have been on a steady uptrend over the last several months, while boasting low implied volatility (IV). What’s more, the sto...
6/30/2021 9:59 AM
Bristol-Myers Squibb Co (NYSE:BMY) is a global biopharmaceutical company that focuses on the discovery, development, and delivery of medications. The company manufactures prescription pharmaceuticals ...
4/13/2021 9:13 AM
The shares of biopharmaceutical name Bristol-Myers Squibb Co (NYSE:BMY) are up 0.6% at $63.07 in pre-market trading, after Truist Securities upgraded the stock to "buy" from hold," with a price-target...
2/1/2021 2:22 PM
The shares of Bristol-Myers Squibb Co (NYSE:BMY) are up 1.6% at $62.39 at last check, just ahead of the pharmaceutical name's fourth-quarter earnings, due out before the open on Thursday, Feb. 4. In ...
10/28/2020 3:01 PM
The shares of Bristol-Myers Squibb Co (NYSE:BMY) are down 1.7% at $57.73 at last check. And while the pharmaceutical name carries a 10% year-to-date deficit, investors should not turn their backs on ...
 
Special Offers from Schaeffer's Trading Partners